A1电台调幅1430与Maggie的访问: 加拿大卫生部主动发布新的药物安全性评价总结

       4月8日，美健药房的Maggie被邀请到A1电台调幅1430回答关于加拿大卫生部主动发布在其网站上的新的药物安全性评价总结的问题。

      在这个月的博客中，我们将解释加拿大卫生部在审批和监管药物安全性的作用。我们还将为您提供可看到张贴安全审查的链接。 

加拿大卫生部是如何确保在加拿大使用的药物是安全的？

      授权在加拿大销售的所有处方药都必须由加拿大卫生部审批和标簽并清楚地列出药品的好处和危害。一旦藥品上市后，加拿大卫生部将继续监测药品的安全性，以确定潜在的安全问题。如果发现藥品有安全问题，就會進行安全审查以确定是否有与健康产品相關的新风险。加拿大卫生部會采取的多项措施包括：

•通知加拿大人或卫生专业人员

•请求更改产品标签

•请求提供附加的信息，研究或更多的监控

•如有必要，撤出加拿大市场。

这些安全评论摘要现在将公布在加拿大卫生部的网站上：

http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/review-examen/index-eng.php

目前，只有1篇关于痤疮的药物Diane-35的安全性的评论文章。

我是否需要查閱我現正服用的药物的安全性评价？我的医生和药剂师是否知道我現正服用的药物的安全性信息的更改？

      加拿大卫生部會通知医生和药剂师有關药品安全性信息的更改，最近加拿大卫生部把藥品的安全审查摘要放到網上，使患者也能看到此信息。本摘要可为病人提供任何审查药物的安全性的新的变更。然而，病人有任何疑虑還是要與他们的医生和药剂师就有关他们目前正在使用的药物的安全性進行讨论。

如果你对你正在服用的药物有问题，我们的药剂师可以帮助你。我们的电话号码是905-305-0111美健药房

A1 radio interview with Maggie on safety reviews of drugs by Health Canada

On April 8^th,  Maggie Cheung, from Custom Care Pharmacy, was invited to A1 radio AM 1430 to answer questions about the new initiative from Health Canada to publish summaries of medication safety reviews on their website. 

For this month’s blog, we will explain the role of Health Canada in approving and monitoring the safety of medications in Canada. We will also provide you with the link to see the posted safety reviews, as well as the Cantonese interview segment on A1 radio. 

Click on the link to listen: http://www.ccue.ca/a1_radio/yangwanwen/  (Choose 上半部 skip to 21:00)

How does Health Canada ensure that drugs available in Canada are safe to use?

All prescription drugs authorized for sale in Canada are required to have approval and labeling from Health Canada that clearly outlines the benefits and harms of the drug product.  Once it is available for sale, Health Canada continues to monitor the safety of drug products to identify potential safety issues. If safety issues are identified, a safety review is conducted to determine if there are new risks associated with the health product. If so, Health Canada may take a number of actions including:

• Notifying Canadians or health professionals

• Requesting changes to the product labeling

• Requesting additional information, studies or more monitoring

• If necessary, withdrawal from the Canadian market.

Summaries of these safety reviews will now be posted on the Health Canada website:

http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/review-examen/index-eng.php

Currently, there is only 1 safety review posted regarding the Acne medication Diane-35.

Do I have to check for safety reviews of the drugs that I am taking? Will my doctor and pharmacist know about changes to the safety information of the drugs that I am taking?

Doctors and pharmacists have always been informed when there are changes to the Health Canada approval and labelling of drug products, including the changes to safety information. What is new is the publishing of the summaries of safety reviews online, which enables patients to see this information as well.  The summaries can provide patients with an awareness of any new changes to the safety profile of the reviewed drug. However, it is important that patients continue to discuss with their doctor and pharmacist regarding any concerns about the safety of the drugs that they are currently using. 

If you have questions about a drug that you are taking,  our pharmacists can help you. Our number is 905-305-0111  CUSTOM CARE PHARMACY